ICICI Prudential Nifty Pharma Index Fund - IDCW
NAV as of Jun 04, 2025
16.220.08%
(Earn upto 0.61% Extra Returns with Direct Plan)
Fund Category:
Equity: Sectoral-Pharma
Expense Ratio:
0.98%(1.54% Category
average)Fund Size:
Rs. 83.25 Cr(0.27% of Investment in Category)
- ADD TO PORTFOLIO
ICICI Prudential Nifty Pharma Index Fund - IDCW
NAV as of Jun 04, 2025
16.220.08%
Expense Ratio:
0.98%
Fund Size:
Rs. 83.25 Cr
Fund Category:
Equity: Sectoral-Pharma
1. Current NAV: The Current Net Asset Value of the ICICI Prudential Nifty Pharma Index Fund as of Jun 04, 2025 is Rs 16.22 for IDCW option of its Regular plan.
2. Returns: Its trailing returns over different time periods are: 13.46% (1yr) and 21.91% (since launch). Whereas, Category returns for the same time duration are: 19.17% (1yr), 22.24% (3yr) and 21.85% (5yr).
3. Fund Size: The ICICI Prudential Nifty Pharma Index Fund currently holds Assets under Management worth of Rs 83.25 crore as on Apr 30, 2025.
4. Expense ratio: The expense ratio of the fund is 0.98% for Regular plan as on May 30, 2025.
5. Exit Load: The given fund doesn't attract any Exit Load.
6. Minimum Investment: Minimum investment required is Rs 1000 and minimum additional investment is Rs 1000. Minimum SIP investment is Rs 1000.
ICICI Prudential Nifty Pharma Index Fund - IDCW Returns
Trailing Returns
Rolling Returns
Discrete Period
SIP Returns
1M 3M 6M 1Y 3Y 5Y Annualized Returns -1.27 7.59 -4.85 14.27 - - Category Avg 1.24 9.78 -4.29 21.19 22.84 20.75 Rank within Category 27 24 20 22 - - No. of funds within Category 24 24 22 20 12 7 - Loading...
- Loading...
Return Comparison
- This Fund
- BenchmarkNIFTY Pharma Total Return Index
Choose from Benchmarks
- S&P BSE Sensex
- Nifty 50
- 1M
- 3M
- 6M
- 1Y
- 5Y
ICICI Prudential Nifty Pharma Index Fund - IDCW Fund Details
Investment Objective - The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index
Fund House | ICICI Prudential Mutual Fund |
Launch Date | Dec 14, 2022 |
Benchmark | NIFTY Pharma Total Return Index |
Return Since Launch | 21.6% |
Riskometer | Very High |
Type | Open-ended |
Risk Grade | - |
Return Grade | - |
ICICI Prudential Nifty Pharma Index Fund - IDCW Investment Details
Minimum Investment (Rs.) | 1,000.00 |
Minimum Additional Investment (Rs.) | 1,000.00 |
Minimum SIP Investment (Rs.) | 1,000.00 |
Minimum Withdrawal (Rs.) | - |
Exit Load | 0% |
Portfolio Allocation
Asset Allocation
Asset Allocation History
Sector Allocation
Market Cap Allocation
Concentration & Valuation Analysis
APR 2025 | MAR 2025 | FEB 2025 | JAN 2025 | DEC 2024 | NOV 2024 | |
---|---|---|---|---|---|---|
Number of Holdings | 20 | 20 | 20 | 20 | 20 | 20 |
Top 5 Company Holdings | 62.62% | 60.88% | 62.08% | 61.62% | 61.49% | 61.55% |
Top 10 Company Holdings | 81.7% | 79.86% | 80.37% | 80.16% | 80.06% | 80.07% |
Company with Highest Exposure | Sun Pharmaceutical Industries (25.51%) | Sun Pharmaceutical Industries (24.74%) | Sun Pharmaceutical Industries (24.66%) | Sun Pharmaceutical Industries (24.96%) | Sun Pharmaceutical Industries (24.72%) | Sun Pharmaceutical Industries (24.77%) |
Number of Sectors | 1 | 1 | 1 | 1 | 1 | 1 |
Top 3 Sector Holdings | 99.9% | 99.32% | 99.85% | 99.9% | 99.9% | 100.27% |
Top 5 Sector Holdings | 99.9% | 99.32% | 99.85% | 99.9% | 99.9% | 100.27% |
Sector with Highest Exposure | Healthcare (99.9%) | Healthcare (99.32%) | Healthcare (99.85%) | Healthcare (99.9%) | Healthcare (99.9%) | Healthcare (100.27%) |
Top Stock Holdings
Sector Holdings in MF
Company Sector Assest(%) P/E EPS-TTM(₹) RETURN 1 YR(%) Sun Pharmaceutical Industries Healthcare 25.51 37.01 45.61 11.94 Cipla Healthcare 11.15 22.87 65.28 -1.67 Dr. Reddy's Laboratories Healthcare 10.1 19.11 67.77 7.47 Divi's Laboratories Healthcare 8.47 80.15 82.53 46.98 Lupin Healthcare 6.47 27.58 71.88 19.23 Aurobindo Pharma Healthcare 5.01 19.27 60.02 -10.08 Alkem Laboratories Healthcare 3.88 26.86 181.11 0.90 Torrent Pharmaceuticals Healthcare 3.85 55.71 56.46 12.83 Zydus Lifesciences Healthcare 3.28 20.86 45.71 -11.17 Glenmark Pharmaceuticals Healthcare 3.09 42.36 37.11 27.82

Peer Comparison
Cumulative Returns
SIP returns
Discrete Returns
Quant Measures
Asset Allocation
Scheme Name NAV(Rs./Unit) Scheme Rating AUM(Rs. Cr) 1M 1Y 3Y 5Y ICICI Prudential Nifty Pharma Index Fund - IDCW 16.22 Unrated 83.25 -1.27 14.27 - - SBI Healthcare Opportunities Fund-IDCW 263.32 3,670.62 -0.12 24.75 27.13 23.49 UTI Healthcare Fund Regular Plan-IDCW 214.32 1,037.49 3.05 26.29 24.87 21.42 ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund-IDCW 24.42 5,295.32 3.48 27.45 27.92 24.71 DSP Healthcare Fund Regular-IDCW 23.86 2,912.01 2.64 20.40 24.13 23.34
Risk Ratios
Ratios are calculated using the calendar month returns for the last 3 years
Risk Ratio data not available for this fund
Fund Manager
- N.P.Nishit PatelSince Nov 202223 schemes
Mr. Patel is a B.Com & Chartered Accountant Prior to joining ICICI Prudential Mutual fund, he has worked with K.K.Dand & Co.
More ICICI Prudential Mutual Fund
Scheme Name | Rating | Asset Size(Cr) | 1M | 3M | 6M | 1Y | 3Y |
---|---|---|---|---|---|---|---|
ICICI Prudential Bluechip Fund-Growth | 68,033.76 | 4.70 | 9.13 | 5.85 | 11.42 | 22.14 | |
ICICI Prudential Balanced Advantage-Growth | 62,527.91 | 2.91 | 6.44 | 5.56 | 11.34 | 14.56 | |
ICICI Prudential Multi Asset Fund-Growth | 57,484.51 | 2.43 | 5.94 | 7.79 | 12.78 | 20.78 | |
ICICI Prudential Liquid Fund-Growth | 53,192.63 | 0.50 | 1.76 | 3.54 | 7.24 | 6.85 | |
ICICI Prudential Value Discovery Fund-Growth | 51,111.88 | 4.65 | 8.55 | 5.60 | 14.30 | 24.31 | |
ICICI Prudential Equity & Debt Fund -Growth | 42,339.71 | 3.06 | 8.66 | 7.01 | 12.28 | 21.60 | |
ICICI Prudential Corporate Bond Fund-Growth | 31,133.02 | 0.96 | 3.29 | 5.06 | 9.39 | 8.00 | |
ICICI Prudential Money Market-Growth | 28,644.02 | 0.66 | 2.38 | 4.16 | 8.07 | 7.35 | |
ICICI Prudential India Opportunities Fund - Growth | 27,197.33 | 4.48 | 8.31 | 6.12 | 14.83 | 27.35 | |
ICICI Prudential Equity Arbitrage-Growth | 26,917.80 | 0.39 | 1.73 | 3.36 | 7.16 | 6.74 |
Mutual Fund Tools
Top AMCs
- SBI Mutual Fund
- ICICI Prudential Mutual Fund
- HDFC Mutual Fund
- Nippon India Mutual Fund
- Kotak Mahindra Mutual Fund
- Aditya Birla Sun Life Mutual Fund
- UTI Mutual Fund
- Axis Mutual Fund
- Mirae Asset Mutual Fund
- Tata Mutual Fund
- DSP Mutual Fund
- Bandhan Mutual Fund
- Edelweiss Mutual Fund
- HSBC Mutual Fund
- Franklin Templeton Mutual Fund
1. ICICI Prudential Nifty Pharma Index Fund is Open-ended Sectoral-Pharma Equity scheme which belongs to ICICI Prudential Mutual Fund House.
2. The fund was launched on Dec 14, 2022.
Investment objective & Benchmark
1. The investment objective of the fund is that " The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index "
2. It is benchmarked against NIFTY Pharma Total Return Index.
Asset Allocation & Portfolio Composition
1. The asset allocation of the fund comprises around 99.9% in equities, 0.0% in debts and 0.1% in cash & cash equivalents.
2. While the top 10 equity holdings constitute around 80.81% of the assets, the top 3 sectors constitute around 99.9% of the assets.
3. The fund largely follows a Blend oriented style of investing and invests across market capitalisations - around 0.0% in giant & large cap companies, 0.0% in mid cap and 0.0% in small cap companies.
Tax Implications on ICICI Prudential Nifty Pharma Index Fund - IDCW
1. Gains are taxed at a rate of 15% (Short-term Capital Gain Tax - STCG) if units are redeemed within 1 year of investment.
2. For units redeemed after 1 year of investment, gains of upto Rs. 1 lakh accruing from those units in a financial year shall be exempted from tax.
3. Gains of more than Rs. 1 lakh will be taxed at a rate of 10% (Long-term Capital Gain Tax - LTCG).
4. For Dividend Distribution Tax, the dividend income from this fund will get added to the income of an investor and taxed according to his/her respective tax slabs.
5. Also, for dividend income in excess of Rs 5,000 in a financial year; the fund house shall deduct a TDS of 10% on such income.
This Might Catch Your Interest
FAQs about ICICI Prudential Nifty Pharma Index Fund - IDCW
- Is it safe to invest in ICICI Prudential Nifty Pharma Index Fund?As per SEBI’s latest guidelines to calculate risk grades, investment in the ICICI Prudential Nifty Pharma Index Fund comes under Very High risk category.
- What is the category of ICICI Prudential Nifty Pharma Index Fund?ICICI Prudential Nifty Pharma Index Fund belongs to the Equity : Sectoral-Pharma category of funds.
- How Long should I Invest in ICICI Prudential Nifty Pharma Index Fund?The suggested investment horizon of investing into ICICI Prudential Nifty Pharma Index Fund is >3 years. The suggested investment horizon is the minimum time required for holding investments in the fund to reduce its downside risk and ensure that the returns become more predictable.
- Who manages the ICICI Prudential Nifty Pharma Index Fund?The ICICI Prudential Nifty Pharma Index Fund is managed by Nishit Patel (Since Nov 25, 2022).
Date Sources: Mutual Funds, ETFs, and NPS data are sourced from Value Research. All times stamps are reflecting IST (Indian Standard Time). By using this site, you agree to the Terms of Service and Privacy Policy.